return to the list »

publication detail

year2022
titleReal-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
journalPHARMACEUTICS
PMID36015214
DOI10.3390/pharmaceutics14081588
reference14(8):
URLhttp://www.ncbi.nlm.nih.gov/pubmed/36015214
authorsThoueille P
Alves Saldanha S
Schaller F
Munting A
Cavassini M
Braun D
Gunthard HF
Kusejko K
Surial B
Furrer H
Rauch A
Ustero P
Calmy A
Stoeckle M
Battegay M
Marzolini C
Andre P
Guidi M
Buclin T
Decosterd LA
On Behalf Of The Swiss Hiv Cohort Study
and the Swiss HIV Cohort Study